Patents by Inventor Subazini Thankaswamy Kosalai

Subazini Thankaswamy Kosalai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220282250
    Abstract: There are provided polynucleotides that is able to bind to and inhibit the long non coding RNA transcript SCAT7. These polynucleotides can be used for the treatment of cancer. Expression analysis of SCAT7 can be used for diagnosis of cancer.
    Type: Application
    Filed: March 17, 2022
    Publication date: September 8, 2022
    Inventors: Chandrasekhar Kanduri, Mohamad Moustafa Mahmoud Ali, Luisa Statello, Vijay Suresh Akhade, Santhilal Subhash, Subazini Thankaswamy Kosalai
  • Patent number: 11306311
    Abstract: There are provided polynucleotides that is able to bind to and inhibit the long non coding RNA transcript SCAT7. These polynucleotides can be used for the treatment of cancer. Expression analysis of SCAT7 can be used for diagnosis of cancer.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: April 19, 2022
    Inventors: Chandrasekhar Kanduri, Mohamad Moustafa Mahmoud Ali, Luisa Statello, Vijay Suresh Akhade, Santhilal Subhash, Subazini Thankaswamy Kosalai
  • Publication number: 20200140861
    Abstract: There are provided polynucleotides that is able to bind to and inhibit the long non coding RNA transcript SCAT7. These polynucleotides can be used for the treatment of cancer. Expression analysis of SCAT7 can be used for diagnosis of cancer.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 7, 2020
    Inventors: Chandrasekhar Kanduri, Mohamad Moustafa Mahmoud Ali, Luisa Statello, Vijay Suresh Akhade, Santhilal Subhash, Subazini Thankaswamy Kosalai